Non-alcoholic Steatohepatitis
📧 Sign up to get email alerts when something new happens for Non-alcoholic Steatohepatitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-17Clinical Trial Update: Research Study on Whether Semaglutide Works in People With Non-alcoholic Steatohepatitis (NASH) [Phase 3]
Phase 3 clinical trial update evaluating semaglutide for non-alcoholic steatohepatitis (NASH); the study is currently active but not recruit…
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: CHronic Hepatopathies Associated With ALcohol Consumption aNd metAbolic Syndrome
ClinicalTrials.gov update announcing an actively recruiting study of chronic liver diseases associated with alcohol use and metabolic syndro…
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: A Study to Evaluate DD01 in Overweight/Obese Subjects With MASLD/MASH [Phase 2]
Phase 2 clinical trial update for DD01 in overweight/obese individuals with MASLD/MASH (NAFLD/NASH), sponsored by Neuraly, Inc.; the study i…
-
CLINICAL_TRIALS trial_result · 2026-04-03Clinical Trial Update: A Study to Test Whether Survodutide Helps People Living With Obesity or Overweight and With a Confirmed or Presumed Liver Disease Called Non-alcoholic Steatohepatitis (NASH) to Reduce Liver Fat and to Lose Weight (SYNCHRONIZE-MASLD) [Phase 3]
Phase 3 clinical trial completion evaluating Survodutide for obesity with non-alcoholic steatohepatitis (NASH) to reduce liver fat and promo…
-
CLINICAL_TRIALS trial_result · 2026-03-27Clinical Trial Update: Study of Oral Idebenone to Treat Non-Alcoholic Steatohepatitis [Phase 1, Phase 2]
A Phase 1/2 trial of oral idebenone for non-alcoholic steatohepatitis with fibrosis has completed and posted results.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-03-19Clinical Trial Update: Simultaneous Quantification of Liver Fat Content, Fatty Acid Composition, and Fibrosis Using Spin-lock MRI for Steatohepatitis Assessment
Clinical trial update evaluating spin-lock MRI to simultaneously quantify liver fat content, fatty acid composition, and fibrosis for assess…
-
CLINICAL_TRIALS research · 2026-03-13Clinical Trial Update: Trial of CS060380 Tablets for Non-alcoholic Steatohepatitis (NASH) [Phase 2]
A Phase 2 clinical trial evaluating CS060380 tablets for Non-alcoholic steatohepatitis (NASH) is currently recruiting.
-
CLINICAL_TRIALS withdrawal · 2026-03-11Clinical Trial Update: Assessment of Fatty Liver With Thermo-acoustic Device
A clinical trial evaluating a thermo-acoustic device for fatty liver diseases has been withdrawn.
-
CLINICAL_TRIALS research · 2026-03-02Clinical Trial Update: Endoscopic Ultrasound Shear Wave Elastography in Patients With Non-alcoholic Fatty Liver Disease
This clinical trial evaluates endoscopic ultrasound shear wave elastography as a diagnostic method in patients with non-alcoholic fatty live…
-
CLINICAL_TRIALS research · 2026-02-24Clinical Trial Update: Identification of Liver Fibrosis Biomarkers
Clinical trial update about identifying biomarkers for liver fibrosis in non-alcoholic fatty liver disease and non-alcoholic steatohepatitis…
-
CLINICAL_TRIALS trial_result · 2026-02-17Clinical Trial Update: Safety, Tolerability, and Pharmacokinetics of ACT500 in Healthy Adult Participants [Phase 1]
Phase 1 study evaluating ACT500 in healthy adult participants, reporting safety, tolerability, and pharmacokinetics in the context of non-al…
-
CLINICAL_TRIALS research · 2026-02-12Clinical Trial Update: "Constitution of a Biological Collection to Establish Preclinical Translational Models for the Study of Tumors and Chronic Liver Diseases".
A French research trial aims to assemble a biological collection to develop preclinical translational models for tumors and chronic liver di…
-
CLINICAL_TRIALS trial_result · 2026-02-11Clinical Trial Update: To Evaluate the Efficacy and Safety of HSK31679 in Chinese Patients With Non-Alcoholic Steatohepatitis (NASH) . [Phase 2]
A Phase 2 clinical trial update reports completion of the study evaluating HSK31679 for efficacy and safety in Chinese patients with non-alc…
-
CLINICAL_TRIALS research · 2026-02-09Clinical Trial Update: Integrated Diagnostics for Early Diagnosis of Liver Disease
This clinical trial entry reports that a study on integrated diagnostics for early detection of liver disease is currently recruiting, evalu…
-
CLINICAL_TRIALS trial_result · 2026-01-27Clinical Trial Update: Pediatric Liver Fat Quantification (LFQ) Phase 2 Pilot Study [NA]
A Phase 2 pediatric pilot trial evaluating liver fat quantification (LFQ) has completed. Results have been posted.
-
CLINICAL_TRIALS trial_result · 2026-01-23Clinical Trial Update: Ultrasound-Based Liver Fat Quantification (LFQ) Pilot Study [NA]
A completed pilot trial evaluating ultrasound-based liver fat quantification for non-alcoholic fatty liver disease and non-alcoholic steatoh…
-
CLINICAL_TRIALS research · 2026-01-16Clinical Trial Update: The Olmsted NAFLD Epidemiology Study (TONES) [NA]
ClinicalTrials.gov entry for the Olmsted NAFLD Epidemiology Study (TONES) shows the study is currently recruiting participants for non-alcoh…
-
CLINICAL_TRIALS trial_result · 2025-12-23Clinical Trial Update: Phase 2 Study of MGL-3196 in Patients With Non-Alcoholic Steatohepatitis (NASH) [Phase 2]
Phase 2 study of MGL-3196 (resmetirom) in non-alcoholic steatohepatitis has completed, with results posted on 2025-12-23.
-
CLINICAL_TRIALS trial_result · 2025-12-23Clinical Trial Update: Diagnostic Accuracy of the "LLIFT", a Novel Non-invasive Biomarker for the Diagnosis of Non Alcoholic Fatty Liver (NAFL) and SteatoHepatitis (NASH) in a Population With High Risk of Metabolic Syndrome"
This completed trial assesses the diagnostic accuracy of LLIFT, a novel non-invasive biomarker, for diagnosing non-alcoholic fatty liver dis…
-
CLINICAL_TRIALS trial_result · 2025-12-18Clinical Trial Update: Exploratory Study to Assess the Short Term Effect on Liver Enzymes and the Safety of TRO19622 in Patients With Non-Alcoholic Steatohepatitis (NASH) [Phase 2]
This ClinicalTrials.gov update describes a Phase 2 exploratory trial evaluating the short-term effect on liver enzymes and the safety of TRO…
-
CLINICAL_TRIALS trial_result · 2025-12-17Clinical Trial Update: Investigate Safety, Tolerability, PK/PD of J2H-1702 in Healthy Females [Phase 1]
Phase 1 study completed evaluating safety, tolerability, and pharmacokinetics/pharmacodynamics of J2H-1702 in healthy female volunteers, wit…
-
CLINICAL_TRIALS trial_result · 2025-12-17Clinical Trial Update: Investigate Safety, Tolerability, PK/PK of J2H 1702 in Healthy Males [Phase 1]
This document reports the completion of a Phase 1 trial evaluating the safety, tolerability, and pharmacokinetics of J2H 1702 in healthy mal…
-
CLINICAL_TRIALS trial_result · 2025-12-17Clinical Trial Update: Phase 2a Study to Evaluate Safety and Explore Efficacy of J2H-1702 for NASH [Phase 2]
Phase 2a trial evaluating the safety and preliminary efficacy of J2H-1702 in non-alcoholic steatohepatitis has completed.
-
CLINICAL_TRIALS research · 2025-12-05Clinical Trial Update: Non-alcoholic Fatty Liver Disease Parametric PET (FLiPP) Study
This clinical trial update describes the FLiPP (Non-alcoholic Fatty Liver Disease Parametric PET) study evaluating PET imaging for NAFLD and…
-
CLINICAL_TRIALS research · 2025-12-02Clinical Trial Update: A Physiologic Analysis of Endoscopic Sleeve Gastroplasty (ESG) [NA]
This clinical trial update outlines a physiologic analysis of Endoscopic Sleeve Gastroplasty (ESG). It addresses conditions including non-al…